Regenerative Medicine Crossroad in Tokyo #11<\/a> conference!<\/span>
<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"Today, Maxime Feyeux, President and CSO of TreeFrog Therapeutics, presented the C-Stem\u2122 technology at the Regenerative Medicine Crossroad in Tokyo #11 conference!<\/p>\n","protected":false},"author":1,"featured_media":805,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[14,12],"tags":[],"aioseo_notices":[],"yoast_head":"\n
TreeFrog in Tokyo! - TreeFrog Therapeutics I iPS-derived cell therapies<\/title>\n\n\n\n\n\n\n\n\n\n\n\t\n\t\n\t\n\n\n